Table 1.

Patient inclusion into the analysis

No.	Inclusion criterion	Patients	Prescriptions			Inclusion in analysis of
			All MPs	AMPs	Non-AMPs
1	≥ 1 MP prescription 1997–2010	88,682	863,340	336,265	527,075
2	≥ 1 MP prescription 2001–2010	88,672	863,270	336,238	527,032
3	No. 2 + ≥1 AMP prescription	62,956	756,757	336,238	420,519
4	No. 3 + ≥1 physician consultation after AMP prescription (2001–2011)	44,662	717,545	311,731	405,814	MP prescriptions ADR, Grades III–IV only
5	No. 4 + patient of prescriber physician	12,956	243,147	94,734	148,413	MP prescriptions ADR, Grades I–IV

ADR adverse drug reactions, AMP anthroposophic medicinal product, MP medicinal product, non-AMP all medicinal products except AMPs